Giorgio Zauli Selected Research

Neuroblastoma

9/2003	TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release.
7/2003	Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio Zauli Research Topics

Disease

33	Neoplasms (Cancer) 07/2023 - 01/2004
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2022 - 04/2006
16	Inflammation (Inflammations) 02/2024 - 01/2007
9	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 01/2004
8	COVID-19 12/2022 - 01/2020
7	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 08/2012
7	Necrosis 01/2019 - 07/2003
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 03/2015
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2014 - 06/2002
5	Diabetes Mellitus 12/2013 - 10/2006
5	Lymphoma (Lymphomas) 04/2012 - 01/2002
4	Fibrosis (Cirrhosis) 08/2023 - 09/2011
4	Atherosclerosis 02/2023 - 10/2006
4	Type 2 Diabetes Mellitus (MODY) 11/2022 - 12/2006
3	Myocardial Infarction 08/2023 - 05/2010
3	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2011
3	Hyperglycemia 01/2022 - 07/2007
3	Body Weight (Weight, Body) 01/2018 - 05/2010
3	Insulin Resistance 01/2018 - 12/2012
3	Overweight 01/2017 - 04/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2015 - 05/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2018
2	Pathologic Processes 08/2023 - 01/2018
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2023 - 01/2018
2	Cataract (Cataracts) 01/2023 - 01/2022
2	Infections 01/2023 - 10/2012
2	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2022 - 01/2022
2	Leukemia 10/2018 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 10/2006
2	Hypoxia (Hypoxemia) 01/2018 - 07/2015
2	Dementia (Dementias) 01/2018 - 01/2016
2	Cognitive Dysfunction 01/2018 - 01/2016
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2016 - 03/2015
2	Diabetes Complications 01/2015 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2014 - 04/2013
2	Heart Failure 01/2014 - 01/2009
2	Rheumatoid Arthritis 09/2010 - 03/2009
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2008 - 02/2005
2	Lymphoid Leukemia 12/2005 - 11/2005
2	Bone Resorption 10/2005 - 10/2004
2	Neuroblastoma 09/2003 - 07/2003
1	Prodromal Symptoms 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Retinal Degeneration 01/2024
1	Poisoning 01/2024
1	Keratoconus 12/2023
1	Dehydration (Water Stress) 12/2023
1	Sensorineural Hearing Loss 12/2023

Drug/Important Bio-Agent (IBA)

26	TNF-Related Apoptosis-Inducing LigandIBA 11/2021 - 08/2003
22	nutlin 3IBA 07/2022 - 05/2006
16	CytokinesIBA 01/2022 - 12/2004
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2002
14	LigandsIBA 01/2018 - 07/2003
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2007
8	OsteoprotegerinIBA 08/2014 - 12/2006
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2012
4	MicroRNAs (MicroRNA)IBA 08/2023 - 08/2010
4	NF-kappa B (NF-kB)IBA 01/2022 - 08/2003
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 04/2012
4	Insulin (Novolin)FDA Link 01/2018 - 07/2007
4	Messenger RNA (mRNA)IBA 04/2013 - 07/2007
4	Therapeutic UsesIBA 08/2012 - 01/2008
3	Retinaldehyde (Retinal)IBA 02/2024 - 01/2022
3	VaccinesIBA 01/2023 - 05/2020
3	Phosphotransferases (Kinase)IBA 10/2018 - 01/2002
3	C-Reactive ProteinIBA 01/2018 - 04/2013
3	Apolipoproteins E (ApoE)IBA 01/2018 - 10/2006
3	Streptozocin (Streptozotocin)FDA Link 12/2013 - 10/2006
3	Macrophage Colony-Stimulating FactorIBA 10/2007 - 10/2004
2	IronIBA 12/2023 - 01/2018
2	Lipoproteins (Lipoprotein)IBA 02/2023 - 01/2018
2	HDL CholesterolIBA 02/2023 - 01/2018
2	LipidsIBA 02/2023 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 01/2018
2	Dasatinib (BMS 354825)FDA Link 07/2022 - 02/2011
2	TOR Serine-Threonine KinasesIBA 01/2022 - 08/2016
2	ibrutinibIBA 01/2021 - 10/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2019 - 04/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2018 - 08/2016
2	perifosineIBA 03/2015 - 04/2011
2	CollagenIBA 09/2011 - 10/2006
2	AntibodiesIBA 08/2011 - 01/2008
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2008 - 07/2003
2	Tartrate-Resistant Acid PhosphataseIBA 10/2005 - 10/2004
1	InflammasomesIBA 02/2024
1	SynucleinsIBA 01/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	5-methoxy-N-methyl,N-isopropyl tryptamineIBA 01/2024
1	Hallucinogens (Psychedelics)IBA 01/2024
1	tryptamineIBA 01/2024
1	SolutionsIBA 12/2023
1	N 30IBA 12/2023

Therapy/Procedure

15	Therapeutics 07/2023 - 01/2004
7	Corneal Transplantation (Keratoplasty) 12/2023 - 01/2022
5	Drug Therapy (Chemotherapy) 07/2023 - 01/2004
2	Intraocular Lenses (Intraocular Lens) 01/2023 - 01/2022
2	Aftercare (After-Treatment) 01/2021 - 03/2018
2	Bed Rest (Bedrest) 01/2018 - 12/2012